Warning: Your current browser has not been tested extensively with this website, which may result in some some errors with functionality. The following browsers are fully supported:
Please use a different browser.
Figure D01: Vaccine-Specific Antibody Response (by maternal exposure) presented as beta
Vaccine-specific antibody response relative to maternal PFOA and PFOS presented as standardized regression beta:
Not on this graph - studies presenting antibody response as difference per 2-fold increase PFOA and PFOS:
- Granum (2013) - cohort tested association between maternal PFOA or PFOS associated with antibody response to Hib, measles, rubella, tetanus vaccination in children
- Maternal [RED triangles] PFOA and PFOS associated with reduced antibody response to rubella
- No association between maternal PFOA or PFOS and antibody response to other vaccines (Hib, measles, tetanus)
- Different symbols for different vaccines
- Red symbols are reported as statistically significant
- Black Line separate PFOA top and PFOS bottom
Not on this graph - studies presenting antibody response as difference per 2-fold increase PFOA and PFOS:
- Grandjean (2012) - cohort tested association with maternal and child PFOA and PFOS with antibody response to tetanus and diphtheria vaccination in children
- Stein (2015) - cross-sectional study tested association with current child PFOA and PFOS with antibody response to measles, mumps, rubella vaccination in children
- Kielsen (2015) - cohort tested association between PFOA or PFOS and antibody response to tetanus and diphtheria vaccination in small study of adults
- Looker (2014) - cohort tested association between PFOA or PFOS and antibody response to influenza Type B, A/H1N1, A/H3N2 vaccination in adults